MRKAd5+6 Trigene (V526)

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRKAd5+6 Trigene (V526), covering 2015-11-02 to 2015-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED) [Phase 1]